drugset / Trial / NCT01218308

A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children

NCT01218308

Phase 3 Completed 5220 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindPrevention

Summary

This study is designed to test the efficacy of an investigational influenza vaccine, in children compared to Havrix®, a licensed Hepatitis A virus vaccine. This study will also evaluate the immunogenicity and safety of the investigational vaccine.

Timeline

Start
2010-12-09
Primary completion
2012-01-09
Completion
2012-01-09

Drugs

EvaluationDrugModalityDoseRoute
Subject FluLaval® Quadrivalent Vaccine Intramuscular
Comparator Havrix Vaccine Intramuscular

Indications